Researchers at the University of Calgary in Canada are conducting further trials after early studies revealed that vitamin B3, or niacin, holds…
According to a poll conducted by Gallup in March, Americans are most concerned about healthcare. This finding is notable given the…
Disseminated on behalf of MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF)and may include paid advertising. The company has appointed Chilean drug…
A recently published report by Mordor Intelligence analyzes future projections, growth drivers and the key trends that are shaping the…
Publishing research in peer-reviewed journals plays a central role in ensuring the credibility and reliability of scientific findings. Companies that…
LIXTE’s lead compound, LB-100, is the world’s first and only clinical-stage inhibitor of protein phosphatase 2A (“PP2A”). LB-100 helps in…
A team of scientists from Texas Children’s Hospital, University of Pittsburgh and Baylor College of Medicine has discovered the primary driver of…
In the life sciences industry, a robust pipeline is widely recognized as a critical driver of value creation and sustainability.…
Cardiovascular disease remains the leading cause of death in the United States, representing a significant and persistent healthcare burden that…
Researchers are increasingly focused on combination therapies and novel mechanisms of action that can enhance tumor response to treatment. LIXTE’s…